Novartis (NVS) agreed to acquire AveXis (AVXS) for $8.7 billion on Monday. 

"This is squarely in the crosshairs of Biogen (BIIB) which has that great deal with Ionis (IONS) ," said TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer.

Want exclusive investing insight from Jim Cramer? Get 24/7 access to Jim's charitable trust portfolio with a free trial to Action Alerts PLUS!

Watch all of Jim Cramer's full NYSE live shows right here:

More from Video

Norwegian CFO Mark Kempa's Key Insights on Cruising in 2019

Norwegian CFO Mark Kempa's Key Insights on Cruising in 2019

CES 2019: The Future Is Here and it's a Walking Car

CES 2019: The Future Is Here and it's a Walking Car

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

The Story Behind One of America's Biggest Banks - Wells Fargo

The Story Behind One of America's Biggest Banks - Wells Fargo

Financing History: How Citigroup Grew Into a Banking Powerhouse

Financing History: How Citigroup Grew Into a Banking Powerhouse